Developing countries need additional, cross-border capital channeled into their private sectors to generate employment and growth, reduce poverty, and meet the other Millennium Development Goals. Innovative financing mechanisms are necessary to make this happen. 'Innovative Financing for Development' is the first book on this subject that uses a market-based approach. It compiles pioneering methods of raising development finance including securitization of future flow receivables, diaspora bonds, and GDP-indexed bonds. It also highlights the role of shadow sovereign ratings in facilitating access to international capital markets. It argues that poor countries, especially those in Sub-Saharan Africa, can potentially raise tens of billions of dollars annually through these instruments. The chapters in the book focus on the structures of the various innovative financing mechanisms, their track records and potential for tapping international capital markets, the constraints limiting their use, and policy measures that governments and international institutions can implement to alleviate these constraints.

United States (US) has one of the deepest pools of potential investors of any country. It has more than 33 million total investors, both accredited and non-accredited. It has been reported that over 9 million US households qualify as accredited investors, with a net worth of over $1 million (exclusive of primary residence). It has also been reported that, in US, there are over 700,000 “angel investors” who are willing to invest their own money in ranges of $150,000 to $2 million. This book will describe three new methods of raising capital from US investors which have recently been approved. It also analyzes strategies for successfully implementing these finance methods.This book is intended for entrepreneurs (both US and international) who are thinking of growing their business with outside capital from US. It will be of importance for all start-up and middle-market companies who are in need of additional capital to grow their businesses.

The venture capital model doesn’t work—at least not for 99% of startups and small businesses. In this 99% are a lot of companies with incredible potential: businesses headed by female founders and those from diverse racial backgrounds, organizations headquartered outside of venture capital hubs, and purpose-driven enterprises that are creating social and environmental impact alongside financial success. Counter to what the press-savvy venture capital world would have you believe, there are a lot of funding options out there for startups and small businesses. Adventure Finance is designed to help you understand some of these options, and walk you through real examples of how other founders and funders have put them to use. In simple, approachable language, the book breaks down the different types of funding options available from revenue-based financing to recoverable grants to redeemable equity to distributed ownership and more. Through a mix of storytelling and frameworks, based on a decade of research and experience in investing in early-stage companies, this book will give you the ability to determine how each of these structures can contribute to your own funding journey. The goal for this book is to shift the conversation about startup funding and help founders and funders widen the spectrum of “mainstream” investment options in order to make the venture financing world more inclusive and purpose-driven.

Why healthcare finance? -- From the laboratory to the patient -- Present value relations -- Evaluating business opportunities -- Valuing bonds -- Valuing stocks -- Portfolio management and the cost of capital -- Therapeutic development and clinical trials -- Decision trees and real options -- Monte Carlo simulation -- Healthcare analytics -- Biotech venture capital -- Securitizing biomedical assets -- Pricing, value, and ethics -- Epilogue : a case study pf royalty pharma.

This book gathers pioneering experiences based on the same concept: innovation. According to Schumpeter's research, there would be four types of innovations: product or service innovation (market introduction of a new type of good), process innovation (introduction of a new type of production), market innovation (introduction of a new market in a country or a new market structure), and innovation of matter (introduction of a new raw material). This book contains ten chapters organized in four main sections: (a) "Strategic Issues," (b) "Risk Management in Innovative Projects," (c) "Economic Issues and Financing Innovation," and (d) "Leadership and Teamwork."

The book provides an in-depth description of cross-border project financing as a technique for financing capital-intensive projects as well as an overview of certain financing and derivative instruments currently available in the global financial markets."--BOOK JACKET.

The authors offer creative, street-smart financing techniques for raising capital for any type of business anywhere in the country, no matter what the circumstances. Nontraditional methods of achieving one's goals are outlined, using fresh and innovative sources of financing that are available to anyone with a winning idea or business.

While much progress has been made on achieving the Millenium Development Goals over the last decade, the number and complexity of global health challenges has persisted. Growing forces for globalization have increased the interconnectedness of the world and our interdependency on other countries, economies, and cultures. Monumental growth in international travel and trade have brought improved access to goods and services for many, but also carry ongoing and ever-present threats of zoonotic spillover and infectious disease outbreaks that threaten all. Global Health and the Future Role of the United States identifies global health priorities in light of current and emerging world threats. This report assesses the current global health landscape and how challenges, actions, and players have evolved over the last decade across a wide range of issues, and provides recommendations on how to increase responsiveness, coordination, and efficiency â€" both within the U.S. government and across the global health field.